GSS EU Science Funding Gateway

Proposals should address all of the following:

• Any PRD disease or group of PRDs affecting sub-Saharan Africa.
• Combine health technologies with other scientific areas such as mobile technologies and digital technologies, big data processing, and other emerging technologies.
• Implement one or more medium-scale clinical trials and/or clinical research studies that can deliver the proof-of-concept or validate smart, highly innovative health technologies or concepts to prevent, treat or diagnose PRDs in sub-Saharan Africa, drawing lessons from the COVID-19 experience.
• Increase collaboration with investors in development cooperation and international partnerships to create solutions for improved development or delivery of medical interventions for vulnerable populations in low-resource settings.
• Proposals involving pharmaceutical companies and small- or medium-sized enterprises (SMEs) are encouraged.
• Develop solutions that are easily integrated or linked to existing electronic or digital systems that are used in the implementation of clinical research and health systems’ patient management.
• Include activities that promote collaboration with ongoing and future EDCTP projects. In this context the granting authority may share project-relevant information with the EDCTP Association and the future EDCTP3 Joint Undertaking.
• Promote the integration of research work and health care service delivery.